John Schieszer

Contributing Writer https://www.renalandurologynews.com

John Schieszer is an award winning medical journalist who produces The Medical Minute podcasts. John received his BA in journalism from the University of Missouri-Columbia School of Journalism and his MA in english from the University of Missouri-St. Louis. In 1990, John was awarded the Case Western Reserve University School of Medicine’s Third Annual Fellowship for Journalists in Biomedical Research. In 1992, he completed a Medical Fellowship at the Marine Biological Laboratories in Woods Hole, Massachusetts.

All articles by John Schieszer

Practice Management

Leveraging Digital Tools to Improve Hospital Discharge Preparedness

John Schieszer

March 4, 2021

Results of a recent study suggest possible factors that need to be considered when preparing patients for hospital discharge.

Transplantation

Transitional B Cell Cytokines May Predict Kidney Transplant Rejection

John Schieszer

March 3, 2021

Study findings suggest that the ratio of interleukin-10 to tumor necrosis factor-alpha produced by transitional-1 B cells can predict renal allograft outcomes with a lead time of about 8 months.

Chronic Kidney Disease (CKD)

Venous pH May Inform Treatment of CKD-Related Metabolic Acidosis

John Schieszer

September 15, 2020

In patients with acidemia, hypobicarbonatemia conferred a considerable risk of kidney failure requiring renal replacement therapy after adjusting for potential confounders.

Senior woman lying on hospital bed with her doctor standing by using digital tablet.

Chronic Kidney Disease (CKD)

Simplified Creatinine Index Useful as Muscle Mass Marker in HD Settings

John Schieszer

September 4, 2020

A simplified creatinine index reflects the creatinine generation rate of individual patients on hemodialysis.

In this study, a young adult was defined as an individual who was 40 years or younger.

Kidney Cancer

Approach Immune Checkpoint Inhibitor Rechallenge Cautiously After Initial Immune-Related Adverse Events

John Schieszer

May 7, 2020

Researchers suggest appropriate monitoring and use of standard treatment algorithms to identify and treat toxic effects after a rechallenge after irAEs in patients receiving ICI therapy.

Prostate Cancer

Study: Earlier Use of Radium-223 May Offer Survival Edge

John Schieszer

May 7, 2020

Men with metastatic castration-resistant prostate cancer and symptomatic bone metastases had longer survival times when they received radium-223 as first-line therapy compared with those who received the drug as third-line therapy.

Prostate Cancer

Salvage Radiotherapy Called a Viable Option for Recurrent Prostate Cancer

John Schieszer

March 13, 2020

The authors of new review say the results of the JCOG0401 trial suggest that standard hormonal therapy alone vs salvage radiotherapy is not an appropriate management strategy for recurrence after radical prostatectomy.

Urology

Do Patients With Cancer Need Disease-Specific Precautions to Prevent COVID-19 Infection?

John Schieszer

March 13, 2020

Although some patients with cancer are at higher risk of developing severe disease should they become infected, these experts suggest the precautions being given to the general population are sufficient — at least for now.

Conferring with a patient about treatment.

Urology

Screening for Frailty May Improve Outcomes for Older Patients With Genitourinary Malignancies

John Schieszer

February 19, 2020

The VES-13, a brief frailty screening tool, was found effective in determining which older patients with GU cancer were at higher risk for adverse outcomes and would benefit from a CGA.

Kidney Cancer

Targeted Assessments May Be Needed for Some Patients With Localized Renal Cell Carcinoma

John Schieszer

February 19, 2020

Assessments and interventions for younger and female patients with RCC may need to be targeted, as these patients may have a greater fear of disease recurrence.

Next post in Kidney Cancer